(Q52196702)

26 April 2018

title

In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. (English)

1 reference

26 April 2018

1 reference

Delobette S

1

1 reference

26 April 2018

Privat A

series ordinal

2

1 reference

26 April 2018

Maurice T

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

26 April 2018

European Journal of Pharmacology

published in

1 reference

26 April 2018

volume

319

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

1-4

1 reference

26 April 2018

Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Effects of an exogenous beta-amyloid peptide on retention for spatial learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

beta-Amyloid protein-induced Alzheimer's disease animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

The molecular pathology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Lack of long-term effects after beta-amyloid protein injections in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900922-3

10.1016/S0014-2999(96)00922-3

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018